Hikma Pharmaceuticals
About Hikma Pharmaceuticals
Hikma is a London-listed multinational generics and injectables manufacturer with a large US and MENA presence.
Milestones
Milestones as listed on hikma.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Leadership Team
Leadership as listed on hikma.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Products & Services
Products and services as listed on hikma.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Specialty pharmaceuticals
Specialty and branded medicines business.
Source: hikma.comPipeline & Regulatory Record
What public registers list for Hikma Pharmaceuticals: clinical trials it sponsors, FDA device clearances, Irish licences, recent approvals and supply shortages. Rebuilt daily, last on 10 Oct 2026.
Recent approvals
- Buprenorphine Hydrochloride And Naloxone HydrochlorideFDA · Buprenorphine Hydrochloride, Naloxone Hydrochloride · 27 Jun 2014 · Generic (ANDA)
- Hydromorphone HydrochlorideFDA · Hydromorphone Hydrochloride · 29 Jul 1998 · Generic (ANDA)
How this is matched: register records are linked to this page by the organisation name they carry, here HIKMA. Spot a wrong match? Tell us.